Correction: Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation

Jian Gu^#^{1

2}, Xiaozhang Xu^#³, Xiangyu Li^#³, Lei Yue^#⁴, Xiaowen Zhu^#^{5

6}, Qiuyang Chen^{5

6}, Ji Gao^{5

6}, Maruyama Takashi⁷, Wenhu Zhao^{5

6}, Bo Zhao⁸, Yue Zhang⁸, Minjie Lin⁹, Jinren Zhou^{5

6}, Yuan Liang^{5

6

10}, Shipeng Dai^{5

6}, Yufeng Pan^{5

6

11}, Qing Shao^{5

6}, Yu Li^{5

6}, Yiming Wang^{5

6}, Zibo Xu^{5

6}, Qufei Qian^{5

6}, Tianning Huang^{5

6}, Xiaofeng Qian^{12

13}, Ling Lu^{14

15

16}

Affiliations

¹ Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University and Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, China. Gujian@njmu.edu.cn.
² Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China. Gujian@njmu.edu.cn.
³ Department of General Surgery, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.
⁴ Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
⁵ Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University and Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, China.
⁶ Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
⁷ National Institutes of Health (NIH), New York, NY, USA.
⁸ National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, China.
⁹ The Clinical Skills Training Center, The Second Xiangya Hospital of Central South University, Changsha, China.
¹⁰ School of Biological Science & Medical Engineering, Southeast University, Nanjing, China.
¹¹ School of Medicine, Southeast University, Nanjing, China.
¹² Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University and Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, China. qianxiaofeng@njmu.edu.cn.
¹³ Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China. qianxiaofeng@njmu.edu.cn.
¹⁴ Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University and Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, China. lvling@njmu.edu.cn.
¹⁵ Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China. lvling@njmu.edu.cn.
¹⁶ Department of General Surgery, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China. lvling@njmu.edu.cn.

^# Contributed equally.

PMID: 40456867
PMCID: PMC12143973
DOI: 10.1038/s41388-025-03439-4

Published Erratum

Correction: Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation

Jian Gu et al. Oncogene. 2025 Jul.

. 2025 Jul;44(24):2004-2007.

doi: 10.1038/s41388-025-03439-4.

Authors

Affiliations

¹ Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University and Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, China. Gujian@njmu.edu.cn.
² Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China. Gujian@njmu.edu.cn.
³ Department of General Surgery, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.
⁴ Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
⁵ Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University and Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, China.
⁶ Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
⁷ National Institutes of Health (NIH), New York, NY, USA.
⁸ National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, China.
⁹ The Clinical Skills Training Center, The Second Xiangya Hospital of Central South University, Changsha, China.
¹⁰ School of Biological Science & Medical Engineering, Southeast University, Nanjing, China.
¹¹ School of Medicine, Southeast University, Nanjing, China.
¹² Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University and Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, China. qianxiaofeng@njmu.edu.cn.
¹³ Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China. qianxiaofeng@njmu.edu.cn.
¹⁴ Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University and Research Unit of Liver Transplantation and Transplant Immunology, Chinese Academy of Medical Sciences, Nanjing, China. lvling@njmu.edu.cn.
¹⁵ Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China. lvling@njmu.edu.cn.
¹⁶ Department of General Surgery, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China. lvling@njmu.edu.cn.

^# Contributed equally.

PMID: 40456867
PMCID: PMC12143973
DOI: 10.1038/s41388-025-03439-4

No abstract available

PubMed Disclaimer

Erratum for

Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation.
Gu J, Xu X, Li X, Yue L, Zhu X, Chen Q, Gao J, Takashi M, Zhao W, Zhao B, Zhang Y, Lin M, Zhou J, Liang Y, Dai S, Pan Y, Shao Q, Li Y, Wang Y, Xu Z, Qian Q, Huang T, Qian X, Lu L. Gu J, et al. Oncogene. 2024 Jul;43(31):2389-2404. doi: 10.1038/s41388-024-03080-7. Epub 2024 Jun 18. Oncogene. 2024. PMID: 38890429 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction: Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation

Affiliations

Correction: Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources